Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
Clinical trial NCT05800223 · RECRUITING
Trial details
- NCT number
- NCT05800223
- Sponsor
- Shanghai Cancer Hospital, China
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2027-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.